|
|
||||||||
J Thorac Cardiovasc Surg 2003;126:892-893
© 2003 The American Association for Thoracic Surgery
Brief communications |
a Center for Aortic Surgery, Marfan Syndrome and Connective Tissue Disease Clinic, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
b Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Received for publication February 19, 2003; accepted for publication March 24, 2003.
* Address for reprints: Lars G. Svensson, MD, PhD, Director, Center for Aortic Surgery, Marfan Syndrome and Connective Tissue Disease Clinic, The Cleveland Clinic Foundation, 9500 Euclid Ave/Desk F25, Cleveland, OH 44195, USA
svenssl{at}ccf.org
The relationship between the size of the aorta, in particular the cross-sectional area, and the patients height expressed as a ratio and the risk of aortic dissection has not been determined in patients with bicuspid aortic valves.
Methods and patients
Between January 4, 1993, and September 9, 2002, 430 patients underwent surgical intervention for bicuspid aortic valves and ascending aorta with or without aortic arch repair by the authors at either the Lahey Clinic or The Cleveland Clinic Foundation. Forty patients had aortic dissection, and 25 dissections were acute. Thirty-six patients were male, and 4 were female. The mean age was 49.8 years ± 13.4 years (range, 1780 years). Six patients had grade 0 aortic valve regurgitation, 5 had 1+, 10 had 2+, 7 had 3+, 2 had 4+, and 7 had aortic valve stenosis. Ten patients had separate aortic valve replacements, 26 had composite valve grafts, and 3 underwent aortic valve repair and root remodeling or reimplantation operations.
Hospital charts, including results of computed tomographic, magnetic resonance imaging, and echocardiographic studies, were reviewed to determine the size of the aorta recorded before aortic replacement. In addition, the maximal cross-sectional area in square centimeters was obtained. This was divided by the patients height in meters so that a ratio could be determined as follows:
![]() | (1) |
Results
Thirty-eight (95%) of the 40 patients were 30-day in-hospital survivors. Four (10%) patients had a stroke, and 2 strokes were permanent. For the 390 nondissection patients, 385 (98.7%) were 30-day survivors.
Table 1 shows aortic diameters. Of interest, 5 (12.5%) patients had an aortic diameter of less than 5 cm. The mean diameter of the aorta was 6.02 ± 1.47 cm (range, 310.8 cm). The mean ratio was 18.34 ± 8.88 (range, 754). Figure 1 shows the relationship of aortic cross-sectional size to height. Note that dissection occurred at a smaller diameter for shorter patients. As expected from the formula, the risk of dissection was constant for any given height according to the ratio (Figure 2).
|
|
|
The reason for operating on asymptomatic patients with dilated aortas is to prevent rupture or aortic dissection. Most surgeons recommend operations when the aortic diameter exceeds 5.5 cm in size. Of note (Table 1), 35% of patients had dissections at 5.5 cm or less. Studies have shown that the average size at which dissection or rupture occurs in the ascending aorta is 5.9 cm.2 In patients with Marfan syndrome, recommendations for repair of the aorta have included 5 cm, 5.5 cm, 1.5 times the normal-sized aortic arch, or a cross-sectional area/height ratio exceeding 10.1,3,4
The empiric use of 1.5 or even 2.0 times the aortic arch size has been shown for patients with Marfan syndrome in a prospective prophylactic ß-blocker study to be inadequate in preventing aortic dissection.1 Furthermore, the present use of axial computed tomography or magnetic resonance imaging studies rather than anterior oblique angiograms makes determination of the midaortic arch size difficult to quantify.
On the basis of this study, it is clear that aortic dissection can occur at a smaller size than generally perceived. Fifteen percent of patients with Marfan syndrome have aortic dissection at a size of less than 5 cm.1,3 In this study the number is similar (12.5%). Both in patients with bicuspid valverelated aneurysms and patients with the Marfan syndrome, loss of elastic tissue in the aortic wall is a hallmark. These data would suggest that the risk of aortic dissection in patients with bicuspid valves, according to size or ratio, is not dissimilar from that in patients with the Marfan syndrome.1,3,4 The correlation of normal aortic size to height has previously been documented in the Framingham study.5 Indexing the cross-sectional area of aneurysms to the patients height would take into account the likely greater risk of dissection for the equivalent size in short patients when compared with tall patients, as shown in Figure 1.1 Use of the cross-sectional area also takes into account the likely exponential risk of dissection or rupture related to increasing aortic size because the radius squared is used in the calculation rather than the linear variable of diameter.1 Figure 2 confirms that the risk is constant according to height if the ratio is calculated. Furthermore, as in patients with the Marfan syndrome,1 if patients had undergone surgical intervention for a ratio of greater than 10, 95% of dissections would theoretically have been prevented. Indeed, with a mean ratio of 18.34 and subtraction of 1 SD (8.88), the ratio would be 9.46.
Because of the low operative risk for elective bicuspid valve repair or replacement and aortic surgery, (98.7% in our experience), we would recommend more aggressive treatment for asymptomatic aortic aneurysms and that an aorta of greater than 4.5 cm or a ratio of greater than 10 be repaired for symptomatic bicuspid aortic valve disease.
References
This article has been cited by other articles:
![]() |
L. M. Parish, J. H. Gorman III, S. Kahn, T. Plappert, M. G. St. John-Sutton, J. E. Bavaria, and R. C. Gorman Aortic size in acute type A dissection: implications for preventive ascending aortic replacement Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 941 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Tadros, M. D. Klein, and O. M. Shapira Ascending Aortic Dilatation Associated With Bicuspid Aortic Valve: Pathophysiology, Molecular Biology, and Clinical Implications Circulation, February 17, 2009; 119(6): 880 - 890. [Full Text] [PDF] |
||||
![]() |
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF] |
||||
![]() |
G. D. Pearson, R. Devereux, B. Loeys, C. Maslen, D. Milewicz, R. Pyeritz, F. Ramirez, D. Rifkin, L. Sakai, L. Svensson, et al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on Research in Marfan Syndrome and Related Disorders Circulation, August 12, 2008; 118(7): 785 - 791. [Full Text] [PDF] |
||||
![]() |
L. G. Svensson, N. T. Kouchoukos, D. C. Miller, J. E. Bavaria, J. S. Coselli, M. A. Curi, H. Eggebrecht, J. A. Elefteriades, R. Erbel, T. G. Gleason, et al. Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts Ann. Thorac. Surg., January 1, 2008; 85(1_Supplement): S1 - S41. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Pape, T. T. Tsai, E. M. Isselbacher, J. K. Oh, P. T. O'Gara, A. Evangelista, R. Fattori, G. Meinhardt, S. Trimarchi, E. Bossone, et al. Aortic Diameter >=5.5 cm Is Not a Good Predictor of Type A Aortic Dissection: Observations From the International Registry of Acute Aortic Dissection (IRAD) Circulation, September 4, 2007; 116(10): 1120 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Svensson, E. H. Blackstone, J. Feng, D. de Oliveira, A. M. Gillinov, M. Thamilarasan, R. A. Grimm, B. Griffin, D. Hammer, T. Williams, et al. Are Marfan Syndrome and Marfanoid Patients Distinguishable on Long-Term Follow-Up? Ann. Thorac. Surg., March 1, 2007; 83(3): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, M. D. Cheitlin, M. H. Crawford, and P. S. Douglas Task Force 3: Valvular heart disease J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1334 - 1340. [Full Text] [PDF] |
||||
![]() |
G. B. Luciani, A. Favaro, F. Viscardi, P. Bertolini, and A. Mazzucco Valve-sparing root replacement for pulmonary autograft dissection late after the Ross operation J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 753 - 756. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |